Criminal Justice (Drug Policy)

HR 7413, the HIRE DEA Act, allows the Drug Enforcement Administration (DEA) to directly hire staff for specific roles without following standard federal civil service hiring rules during fiscal years 2027 through 2034. It targets positions critical to combating drug trafficking, including criminal investigators, intelligence analysts, forensic specialists, and community outreach coordinators, as determined by the Attorney General. The bill bypasses most standard hiring procedures under Title 5 of the U.S. Code, except for two specific sections, to speed up recruitment. This change directly affects DEA hiring processes and personnel for roles focused on addressing current and emerging drug trafficking threats.

HR 7599 creates a federal framework for extreme risk protection orders (ERPOs), allowing family members or law enforcement to petition courts to temporarily prohibit individuals from possessing firearms when they pose a risk of harm to themselves or others. The bill establishes a process for issuing ex parte orders (up to 14 days) followed by a hearing within 72 hours to determine if a longer-term order (up to 180 days) should be issued, requiring respondents to surrender firearms to U.S. Marshals or designated law enforcement. Courts must consider specific factors like recent threats, violence, substance abuse, or cruelty to animals before issuing orders, with no fees for petitioners. The law requires law enforcement training to address bias, includes annual reporting requirements, and ensures firearms are returned once the order expires and the individual is eligible to own firearms under federal law.

HR 1064, the "Stopping Overdoses of Fentanyl Analogues Act," adds all fentanyl-related substances to the federal Schedule I list of controlled substances without requiring separate listing. It defines these substances broadly as any chemical structure similar to fentanyl - such as modifications to its phenyl, piperidine, or aniline rings - to automatically cover new synthetic fentanyl analogues created by drug manufacturers. This change treats these substances as illegal fentanyl analogues under existing penalties, meaning law enforcement can prosecute them without proving they meet the current legal definition of a "controlled substance analogue." The bill directly affects drug manufacturers, distributors, and law enforcement by streamlining the regulation of new fentanyl-like compounds designed to evade current laws.

The SAFE Act creates a new category of "fentanyl-related substances" that would automatically be controlled under Schedule I of the Controlled Substances Act based on specific chemical modifications to fentanyl. This affects anyone involved in the production, distribution, or use of substances meeting this broad definition. The bill establishes a process for removing or rescheduling these substances if they're determined to have less potential for abuse than Schedule I substances, and allows courts to review past convictions involving substances that have since been removed from this category. It also creates new research procedures for Schedule I substances and requires a GAO report analyzing the law's implementation and impact within four years.

HR 7699, the Tribal Police Department Parity Act, removes barriers for tribal law enforcement by amending federal firearm and tax laws. It directly affects tribal police departments (as defined under the Indian Self-Determination Act) by allowing them to transfer, possess, and import firearms under the same rules that apply to state police. The bill amends Title 18 (firearm regulations) and the Internal Revenue Code to explicitly include "Indian Tribe" in provisions about firearm transfers and tax exemptions. This ensures tribal departments can access necessary equipment without additional restrictions and qualify for tax exemptions previously limited to state entities. The changes apply to firearms transferred or made after the bill’s enactment.

This bill amends federal housing laws to prevent federally assisted housing programs from banning residents based on marijuana use that complies with state law. It removes prohibitions against "use, distribution, possession, sale, or manufacture of marijuana" that follows state regulations, affecting public housing agencies and residents in federally assisted housing. Key provisions require housing authorities to accept state-compliant marijuana use as non-prohibited activity and mandate smoke-free rules for marijuana in housing similar to existing tobacco policies. The bill explicitly states that state law governs marijuana activity in housing, not federal restrictions.

The Protecting Communities and Preserving the Second Amendment Act of 2025 improves the National Instant Criminal Background Check System (NICS) by requiring federal agencies to share mental health records and implementing accountability measures for grant recipients. It increases penalties for illegal firearm purchases, establishes new programs to prosecute gun violence in high-violence jurisdictions (including a "Nationwide Project Exile Expansion"), and creates regional task forces to combat firearms trafficking. The bill clarifies definitions related to mental health restrictions on firearm possession and modifies rules for interstate transportation of firearms under certain conditions. It also mandates a study on the causes of mass shootings and requires reports on ammunition purchases by federal agencies.

HR 6104, the Dark Web Interdiction Act of 2025, creates a new federal offense for knowingly distributing controlled substances via the dark web and establishes the Joint Criminal Opioid and Darknet Enforcement Task Force. The bill mandates a 2-level sentencing increase for such violations and directs the new task force - comprising agencies like the FBI, DEA, and Customs - to disrupt dark web drug marketplaces through coordinated investigations, forensic training, and international collaboration. It requires annual reports on the task force’s activities and a separate report on virtual currency use in drug trafficking. The law applies directly to law enforcement agencies and targets individuals operating or using dark web marketplaces for illicit drug sales, with a 5-year sunset provision.

Halt All Lethal Trafficking of Fentanyl Act or the HALT Fentanyl Act This act permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. Under the act, offenses involving fentanyl-related substances are triggered by the same quantity thresholds and subject to the same penalties as offenses involving fentanyl analogues (e.g., offenses involving 100 grams or more trigger a 10-year mandatory minimum prison term). Additionally, the act establishes a new, alternative registration process for certain schedule I research. The act also makes several other changes to registration requirements for conducting research with controlled substances, including permitting a single registration for related research sites in certain circumstances, waiving the requirement for a new inspection in certain situations, and allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration. Finally, the act expresses the sense that Congress agrees with the interpretation of the Controlled Substances Act in United States v. McCray , a 2018 case decided by the U.S. District Court for the Western District of New York. In that case, the court held that butyryl fentanyl, a controlled substance, can be considered an analogue of fentanyl even though, under the Controlled Substances Act, the term controlled substance analogue specifically excludes a controlled substance.

The Comprehensive Addiction and Recovery Justice Grant Reauthorization Act (S 2540) extends federal funding for state and local programs that provide addiction treatment and recovery services to individuals involved in the justice system, such as those in courts or correctional facilities. It updates the authorization period from 2019-2023 to 2026-2030, ensuring continued support through 2030 without altering annual funding amounts. This reauthorization directly affects state and local agencies administering these grants, which help connect people with substance use disorders to treatment while navigating legal processes. The bill does not specify new funding levels but secures program continuity by extending the timeframe for grant distribution.